Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Human Somatotropin Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Powder
  • 1.3.3 Solvent
• 1.4 Market Segment by Application
  • 1.4.1 Global Human Somatotropin Market Share by Application (2019-2025)
  • 1.4.2 Growth Hormone Deficiency (GHD)
  • 1.4.3 Turner Syndrome
  • 1.4.4 Chronic Renal Insufficiency
  • 1.4.5 Prader Willi Syndrome
  • 1.4.6 Small for Gestational Age
  • 1.4.7 SHOX Deficiency
  • 1.4.8 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Human Somatotropin Market Size
  • 2.1.1 Global Human Somatotropin Revenue 2014-2025
  • 2.1.2 Global Human Somatotropin Sales 2014-2025
• 2.2 Human Somatotropin Growth Rate by Regions
  • 2.2.1 Global Human Somatotropin Sales by Regions 2014-2019
  • 2.2.2 Global Human Somatotropin Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Human Somatotropin Sales by Manufacturers
  • 3.1.1 Human Somatotropin Sales by Manufacturers 2014-2019
  • 3.1.2 Human Somatotropin Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Human Somatotropin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Human Somatotropin Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Human Somatotropin Market Concentration Ratio (CR5 and HHI)
• 3.3 Human Somatotropin Price by Manufacturers
• 3.4 Key Manufacturers Human Somatotropin Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Human Somatotropin Market
• 3.6 Key Manufacturers Human Somatotropin Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Powder Sales and Revenue (2014-2019)
  • 4.1.2 Solvent Sales and Revenue (2014-2019)
• 4.2 Global Human Somatotropin Sales Market Share by Type
• 4.3 Global Human Somatotropin Revenue Market Share by Type
• 4.4 Human Somatotropin Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Human Somatotropin Sales by Application

6 United States

• 6.1 United States Human Somatotropin Breakdown Data by Company
• 6.2 United States Human Somatotropin Breakdown Data by Type
• 6.3 United States Human Somatotropin Breakdown Data by Application

7 European Union

• 7.1 European Union Human Somatotropin Breakdown Data by Company
• 7.2 European Union Human Somatotropin Breakdown Data by Type
• 7.3 European Union Human Somatotropin Breakdown Data by Application

8 China

• 8.1 China Human Somatotropin Breakdown Data by Company
• 8.2 China Human Somatotropin Breakdown Data by Type
• 8.3 China Human Somatotropin Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Human Somatotropin Breakdown Data by Company
• 9.2 Rest of World Human Somatotropin Breakdown Data by Type
• 9.3 Rest of World Human Somatotropin Breakdown Data by Application
• 9.4 Rest of World Human Somatotropin Breakdown Data by Countries
  • 9.4.1 Rest of World Human Somatotropin Sales by Countries
  • 9.4.2 Rest of World Human Somatotropin Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Novo Nordisk
  • 10.1.1 Novo Nordisk Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Human Somatotropin
  • 10.1.4 Human Somatotropin Product Introduction
  • 10.1.5 Novo Nordisk Recent Development
• 10.2 Pfizer
  • 10.2.1 Pfizer Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Human Somatotropin
  • 10.2.4 Human Somatotropin Product Introduction
  • 10.2.5 Pfizer Recent Development
• 10.3 Eli Lilly
  • 10.3.1 Eli Lilly Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Human Somatotropin
  • 10.3.4 Human Somatotropin Product Introduction
  • 10.3.5 Eli Lilly Recent Development
• 10.4 Merck Serono
  • 10.4.1 Merck Serono Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Human Somatotropin
  • 10.4.4 Human Somatotropin Product Introduction
  • 10.4.5 Merck Serono Recent Development
• 10.5 F. Hoffmann-La Roche
  • 10.5.1 F. Hoffmann-La Roche Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Human Somatotropin
  • 10.5.4 Human Somatotropin Product Introduction
  • 10.5.5 F. Hoffmann-La Roche Recent Development
• 10.6 Ferring Pharmaceuticals
  • 10.6.1 Ferring Pharmaceuticals Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Human Somatotropin
  • 10.6.4 Human Somatotropin Product Introduction
  • 10.6.5 Ferring Pharmaceuticals Recent Development
• 10.7 GeneScience Pharmaceuticals
  • 10.7.1 GeneScience Pharmaceuticals Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Human Somatotropin
  • 10.7.4 Human Somatotropin Product Introduction
  • 10.7.5 GeneScience Pharmaceuticals Recent Development
• 10.8 Ipsen
  • 10.8.1 Ipsen Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Human Somatotropin
  • 10.8.4 Human Somatotropin Product Introduction
  • 10.8.5 Ipsen Recent Development
• 10.9 LG Life Sciences
  • 10.9.1 LG Life Sciences Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Human Somatotropin
  • 10.9.4 Human Somatotropin Product Introduction
  • 10.9.5 LG Life Sciences Recent Development
• 10.10 Sandoz International
  • 10.10.1 Sandoz International Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Human Somatotropin
  • 10.10.4 Human Somatotropin Product Introduction
  • 10.10.5 Sandoz International Recent Development
• 10.11 Anhui Anke Biotechnology

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Human Somatotropin Sales Channels
  • 11.2.2 Human Somatotropin Distributors
• 11.3 Human Somatotropin Customers

12 Market Forecast

• 12.1 Global Human Somatotropin Sales and Revenue Forecast 2019-2025
• 12.2 Global Human Somatotropin Sales Forecast by Type
• 12.3 Global Human Somatotropin Sales Forecast by Application
• 12.4 Human Somatotropin Forecast by Regions
  • 12.4.1 Global Human Somatotropin Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Human Somatotropin Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Human Somatotropin is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Somatotropin.

This report studies the global market size of Human Somatotropin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Human Somatotropin sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology

Market Segment by Product Type
Powder
Solvent

Market Segment by Application
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Human Somatotropin status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Human Somatotropin manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Human Somatotropin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025